Janney Montgomery Scott LLC purchased a new position in VanEck Biotech ETF (NASDAQ:BBH – Free Report) during the fourth ...

Stratos Wealth Partners LTD. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.9% ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.

Making its debut on 01/31/2006, smart beta exchange traded fund SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market. Products that are based ...

You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011. Passively managed ETFs are becoming increasingly popular with institutional as ...

Small biotech stocks have struggled recently, with the SPDR® S&P Biotech ETF down over 15% in the past ten weeks. The pullback has presented significantly lower entry points on myriad small and ...

SPDR ® S&P Biotech ETF earns a Below Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...

This tilt towards the positive has been enough for many biotech stocks, as well as ETFs, to outperform during this troubled time. In fact, several of the ETFs in this space, which we highlight ...